The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
6 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $5,372,931 in first-year total cost, median $986,666.
Most frequent study sections
- Special Emphasis Panel[ZAA1 GG (44)]5
- Special Emphasis Panel[ZAA1 DD (44)]1
Most frequent institutions
- AFASCI, INC.1
- AMYGDALA NEUROSCIENCES, INC.1
- CAMINO PHARMA, LLC1
- DEMERX, INC.1
- KULEON LLC1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Novel and functionally selective 5-HT2C receptor agonist for treating Alcohol Use Disorder1U43AA032128-01 | FOREST, JEREMY | KULEON LLC, WA | $1,001,425 | ZAA1 |
| 2025 | Investigational New Drug (IND)-enabling Study for a New Therapeutic for Alcohol Use Disorder (AUD)1U43AA032129-01 | LLOYD, LINDA S | STRESS THERAPEUTICS, INC., CA | $999,393 | ZAA1 |
| 2025 | Investigational New Drug Development of Noribogaine for Alcohol Use Disorder1R43AA032127-01 | KRAMER, E DOUGLASMASH, DEBORAH C. | DEMERX, INC., FL | $914,324 | ZAA1 |
| 2023 | Investigational New Drug (IND)-enabling and Early-Stage Development of Selective, Reversible, Orally Bioavailable ALDH2 inhibitor ANS-00858 to Treat Alcohol Use Disorder.1U43AA030689-01A1 | BLACKBURN, BRENT KEITH | AMYGDALA NEUROSCIENCES, INC., CA | $1,000,000 | ZAA1 |
| 2023 | Preclinical validation of mGlu2 PAMs in alcohol use disorder1U43AA031388-01 | GADIENT, RETO ANDREASGOULD, ROBERT WARRENSHEFFLER, DOUGLAS J | CAMINO PHARMA, LLC, CA | $973,938 | ZAA1 |
| 2023 | Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase1U43AA031391-01 | XIE, XINMIN SIMONYE, JIANG-HONG | AFASCI, INC., CA | $483,851 | ZAA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.